MARRONE BIO INNOVATIONS INC. Proceeds from Issuance Initial Public Offering
MARRONE BIO INNOVATIONS INC. reported Proceeds from Issuance Initial Public Offering of $13.80 million for the 1-month period ending 2018-04-30, per its 10-K filed 2020-03-16.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceInitialPublicOffering · last filed 2020-03-16
- MARRONE BIO INNOVATIONS INC. proceeds from issuance initial public offering for the quarter ending 2013-12-31 was $0.00.
- MARRONE BIO INNOVATIONS INC. proceeds from issuance initial public offering for fiscal 2013 was $56.10M.
| Period end | Proceeds from Issuance Initial Public Offering 1 month | Proceeds from Issuance Initial Public Offering 3 month | Proceeds from Issuance Initial Public Offering 9 month | Proceeds from Issuance Initial Public Offering 12 month |
|---|---|---|---|---|
| 2018-04-30 | $13.80M 10-K · filed 2020-03-16 | |||
| 2017-04-30 | $8.20M 10-Q · filed 2017-11-14 | |||
| 2013-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-25 | $56.10M 10-K · filed 2014-03-25 | ||
| 2013-09-30 | $56.10M 10-Q · filed 2013-11-08 | |||
| 2013-08-31 | $56.10M 10-K · filed 2017-04-03 |